Narayana Hrudayalaya share price
NSE: NHBSE: 539551Healthcare ServicesMid Cap
Narayana Hrudayalaya Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 2016
Last close ₹1,723.10up ₹9.90 (0.58%)BSE ₹1,723.10
Share price at the NSE close on 28 Oct 2026. Previous close ₹1,713.20.
28 Oct: open ₹1,713.00, high ₹1,735.00, low ₹1,693.10
52-week range of traded prices to 28 Oct 2026
₹1,589.00Low, 2 Apr 2026₹2,093.30High, 17 Nov 2025
- Next results date: the board meets on 30 Oct 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹35,213 Cr235th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 43.15
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 7.76
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.26%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 20.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 13.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.07
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 97,69155.1% delivered
About Narayana Hrudayalaya
Narayana Hrudayalaya Limited runs a network of hospitals and healthcare facilities in India, the Cayman Islands and the United Kingdom, specialising in cardiac surgery and cardiology along with a wide range of other medical services.12 It also runs neighbourhood clinics around its Bengaluru hospitals and sells health insurance through a subsidiary.34
At the end of March 2026 its hospitals and clinics in India spanned 11 states, in cities including Bengaluru, Mysore, Kolkata, Guwahati, Raipur, Jaipur, Delhi, Gurugram, Ahmedabad and Mumbai.2 Health City Cayman Islands, a wholly owned subsidiary, operates a hospital in the Cayman Islands, where Cayman Integrated Healthcare, a subsidiary of a subsidiary, is authorised to sell health insurance.5 In the United Kingdom it bought Practice Plus Group Hospitals, which runs hospitals, surgical centres, urgent treatment centres and diagnostic centres, on 6 Nov 2025.67 Its subsidiary Athma Healthtech develops hospital software, which the group also sells to other hospitals as a service.89
Devi Prasad Shetty, a cardiac surgeon, established the company in 2000 and is its chairman and promoter.1011 The promoter group held 63.3% of the shares at the end of June 2026; Devi Prasad Shetty's sons Viren Prasad Shetty, the executive vice-chairman, and Anesh Shetty, a non-executive director, sit on the board.1213
Narayana Hrudayalaya key points
Results
- In the quarter to Jun 2026, consolidated operating revenue was ₹26,836 million, up 78.0% from a year earlier, before the group owned its UK business, and EBITDA (earnings before interest, tax, depreciation and amortisation) was ₹5,052 million, an 18.8% margin.1415
- Consolidated profit after tax in the quarter to Jun 2026 was ₹2,073 million, a 7.7% margin.16
- In the year to Mar 2026, consolidated operating revenue rose 44.0% to ₹78,960 million, with EBITDA of ₹17,169 million (21.7% margin) and profit after tax of ₹8,105 million (10.3% margin); revenue and EBITDA were the group's highest ever.17
- At the end of June 2026, consolidated net debt (borrowings less cash, bank balances and investments) was ₹19,671 million, a net debt to equity ratio (net debt divided by shareholders' equity) of 0.42.18
Revenue by business
Hospitals and beds
- Healthcare facilities and operational beds at the end of June 20262122In all, 55 facilities with 5,955 operational beds.
Item quarter to Jun 2026 India hospitals and heart centres 20 facilities, 5,461 beds India clinics and dialysis centres 20 facilities Cayman Islands 2 facilities, 164 beds United Kingdom 13 facilities, 330 beds
India hospitals
- EBITDA of the India hospitals business was ₹10,949 million in the year to Mar 2026 (23.1% of revenue), against ₹8,930 million (20.7%) a year earlier.23
- Average revenue per occupied bed (ARPOB) in the India hospitals was ₹19.2 million in the quarter to Jun 2026, against ₹17.6 million a year earlier.24
- On its earnings call of 3 Aug 2026, the company said it intends to bring the average length of a hospital stay in India down to between 3.9 and 4 days, from 4.3 days in the year to Mar 2026.2526
Clinics and insurance
- The clinic business, with 11 integrated care clinics at the end of June 2026, lost about ₹15 crore in the quarter to Jun 2026.2728
- Narayana Health Insurance (India), ₹ million2930The insurer covered more than 1.2 lakh lives at the end of March 2026.
Item quarter to Jun 2026 quarter to Jun 2025 Gross written premium (premiums sold, before reinsurance) 262 17 Loss after tax 201 60 Claims ratio (claims as a share of earned premium) 219% 72% - The Cayman Islands insurer lost about US$3.7 million in the quarter to Jun 2026, against about US$5.2 million in the quarter to Mar 2026; all policies due for renewal that July were renewed at higher prices.3132
United Kingdom business
- Revenue of the UK business grew about 5% in the quarter to Jun 2026 from a year earlier, before the group owned it; a heat wave cost it several days of operating capacity, and the company said the UK business lowered group margins.3334
- On its earnings call of 3 Aug 2026, the company said the UK business was 95% funded by the NHS (the UK's public health service) when bought, and that it expected a move towards its closest peer's about 70% to take 4 to 5 years.35
Expansion and capital spending
- The company stated in its annual report for the year to Mar 2026 that it planned to spend ₹7,300 million in the year to Mar 2027, and that its projects would add about 1,500 beds over 3 to 4 years at about ₹30,000 million.36
- Hospital projects at the end of June 2026: beds and cost3738The company's presentation of 3 Aug 2026 shows timelines shifted for the Kolkata, Central Bangalore and South Bangalore projects.
Item quarter to Jun 2026 Rajarhat, Kolkata (new) 350 beds, ₹9,000 million South Bangalore (new) 350 beds, ₹8,000 million HSR, Bangalore (new) 215 beds, ₹4,900 million Central Bangalore (leased) 220 beds, ₹1,600 million Raipur (expansion) 300 beds South-West Bangalore (leased) 100 beds
Recent events
- KS-Narayana Hospital in Banashankari, Bengaluru, a 110-bed hospital built by the Kammavari Sangham society and operated and managed by the company, began commercial operations on 5 Oct 2026.39
- In its exchange filing of 5 Oct 2026, the company said it had agreed to operate and manage the 100-bed Mission of Mercy Hospital & Research Centre on Park Street, Kolkata; operations depend on conditions that may take up to 12 months.4041
- On 2 Apr 2026 shareholders and creditors approved a scheme to move NH Integrated Care's clinic business into the company; as of its annual report of 24 Jul 2026, the National Company Law Tribunal's final order was awaited.42
- On 19 Jan 2026 shareholders and creditors approved merging the subsidiary Meridian Medical Research & Hospital, which runs 2 hospitals in Howrah, into the company; as of its annual report of 24 Jul 2026, the National Company Law Tribunal's final order was awaited.434445
Last updated
All 45 sources, each with its page
- 1. Exchange filing, 12 Dec 2025, page 5
- 2. Annual report, 24 Jul 2026, page 99
- 3. Annual report, 24 Jul 2026, page 5
- 4. Annual report, 24 Jul 2026, page 51
- 5. Annual report, 24 Jul 2026, page 50
- 6. Exchange filing, 6 Nov 2025, page 1
- 7. Annual report, 24 Jul 2026, page 51
- 8. Annual report, 24 Jul 2026, page 50
- 9. Investor presentation, 3 Aug 2026, page 17
- 10. Annual report, 24 Jul 2026, page 8
- 11. Annual report, 24 Jul 2026, page 137
- 12. Investor presentation, 3 Aug 2026, page 19
- 13. Annual report, 24 Jul 2026, page 87
- 14. Investor presentation, 3 Aug 2026, page 6
- 15. Exchange filing, 6 Nov 2025, page 1
- 16. Investor presentation, 3 Aug 2026, page 6
- 17. Annual report, 24 Jul 2026, page 6
- 18. Investor presentation, 3 Aug 2026, page 6
- 19. Annual report, 24 Jul 2026, page 39
- 20. Annual report, 24 Jul 2026, page 6
- 21. Investor presentation, 3 Aug 2026, page 5
- 22. Investor presentation, 3 Aug 2026, page 5
- 23. Annual report, 24 Jul 2026, page 41
- 24. Investor presentation, 3 Aug 2026, page 9
- 25. Earnings call, 3 Aug 2026, page 12
- 26. Annual report, 24 Jul 2026, page 39
- 27. Investor presentation, 3 Aug 2026, page 5
- 28. Earnings call, 3 Aug 2026, page 18
- 29. Investor presentation, 3 Aug 2026, page 12
- 30. Annual report, 24 Jul 2026, page 41
- 31. Earnings call, 3 Aug 2026, page 15
- 32. Earnings call, 3 Aug 2026, page 13
- 33. Earnings call, 3 Aug 2026, page 14
- 34. Earnings call, 3 Aug 2026, page 13
- 35. Earnings call, 3 Aug 2026, page 18
- 36. Annual report, 24 Jul 2026, page 6
- 37. Investor presentation, 3 Aug 2026, page 16
- 38. Investor presentation, 3 Aug 2026, page 16
- 39. Exchange filing, 5 Oct 2026, page 1
- 40. Exchange filing, 5 Oct 2026, page 1
- 41. Exchange filing, 5 Oct 2026, page 2
- 42. Annual report, 24 Jul 2026, page 59
- 43. Annual report, 24 Jul 2026, page 59
- 44. Annual report, 24 Jul 2026, page 49
- 45. Annual report, 24 Jul 2026, page 58
Results
Consolidated; ₹ crore.Narayana Hrudayalaya quarterly results
- Revenue growth, 12 monthsRevenue growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- +57.8%
- Net profit growth, 12 monthsNet profit growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- +3.9%
Quarter to Jun 2026, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹2,684 Crup 3.46%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent. Net profit in the glossary
- ₹207 Crdown 7.47%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 7.7%
Revenue by quarter
Net profit by quarter, a loss in red
The quarters either side of a change of basis do not compare. From the quarter to Mar 2025, the company's revenue for the year to Mar 2025, ₹5,483 Cr, differs from its quarters added, ₹5,583 Cr.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,400 | 1,367 | 1,475 | 1,507 | 1,644 | 2,151 | 2,594 | 2,684 |
| Net profit | 199 | 193 | 197 | 197 | 258 | 127 | 224 | 207 |
| Net margin | 14.2% | 14.1% | 13.4% | 13.1% | 15.7% | 5.9% | 8.6% | 7.7% |
Consolidated. The last eight quarters. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹7,896 Crup 44.01%
- Net profitNet profit. The pill is the change in net profit against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹806 Crup 1.94%
- Net margin
- 10.2%
Revenue by year
Net profit by year, a loss in red
- Net profit
- Loss
A loss in 1 of the 10 years shown
The years either side of a change of basis do not compare. From the year to Mar 2025, the company's revenue for that year, ₹5,483 Cr, differs from its quarters added, ₹5,583 Cr.
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,878 | 2,281 | 2,861 | 3,128 | 2,582 | 3,701 | 4,525 | 5,018 | 5,483 | 7,896 |
| Net profit | 83 | 51 | 59 | 119 | −14 | 342 | 607 | 790 | 791 | 806 |
| Net margin | 4.4% | 2.3% | 2.1% | 3.8% | −0.6% | 9.2% | 13.4% | 15.7% | 14.4% | 10.2% |
Consolidated. Years to March. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Business segments
Share of revenue, year to Mar 2026, consolidated.Segment revenue and profit
- Medical and healthcare related servicesMedical and healthcare related services, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹7,689 Crup 37.09%95.2%
- OthersOthers, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹386 Cr4.8%
The pill is the change in revenue on the year before; the share is of all the businesses together.
Valuation
Today, against the company's own history. Its history crosses a change of basis in the accounts in the year to Mar 2025: days before it are of the company before the change.Narayana Hrudayalaya PE ratio and valuation
Price to earnings
At or below today's level on 40% of 2,213 trading days since Nov 2016.
LowestHighest
Its median46.55Industry median42.88
Price to book
At or below today's level on 27% of 1,978 trading days since Nov 2018.
LowestHighest
Its median8.78Industry median4.47
Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price. When a year's dividend goes ex later than the year before's, the yield reads zero for the days between; a run of under 60 such trading days is left out of the yield's medians and percentiles. The ex-date is the day from which a buyer of the share no longer gets the dividend.
At or below today's level on 79% of 2,460 trading days over the last 10 years.
LowestHighest
Its median0.14%Industry median0.24%
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −4.8% | +2.0% | −7.0% | 0.3% |
| 3 years | +27.8% | +9.9% | +16.0% | 0.3% |
| 5 years | +31.9% | – | – | 0.3% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record.
Mutual fund holdings
108 funds disclosed a holding for Sep 2026. What they did in Sep 2026, against each fund's month before. 36 of the 47 funds that added or cut are index funds, ETFs or arbitrage funds: an index fund or ETF holds what its index holds, and an arbitrage fund holds the share against a sale of its future.All 108 funds holding Narayana Hrudayalaya
- Bought for the first timeBought for the first time. Funds that held it at the month's end and had not held it in any month on record before.
- 35
- AddedAdded. Funds that held more shares than at the end of the month before.
- 23
- CutCut. Funds that held fewer shares than at the end of the month before.
- 24
- Held unchangedHeld unchanged. Funds that held the same number of shares as at the end of the month before.
- 26
- Sold outSold out. Funds that held it at the end of the month before and hold none at this month's end. Sold out in the glossary
- 23
| Fund | |||
|---|---|---|---|
 Mirae Asset Large & Midcap FundMirae Asset Mutual Fund | 41,79,558 | 1.75% | ₹748.7 Cr |
| Mirae Asset Midcap FundMirae Asset Mutual Fund | 23,28,229 | 2.13% | ₹417.1 Cr |
 Parag Parikh Flexi Cap FundPPFAS Mutual Fund | 19,95,914 | 0.25% | ₹357.5 Cr |
| Mirae Asset ELSS Tax Saver FundMirae Asset Mutual Fund | 16,66,954 | 1.21% | ₹298.6 Cr |
 Axis Small Cap FundAxis Mutual Fund | 16,63,780 | 0.97% | ₹298.0 Cr |
 DSP Small Cap FundDSP Mutual Fund | 11,84,362 | 0.99% | ₹212.2 Cr |
 Nippon India Small Cap FundNippon India Mutual Fund | 9,44,173 | 0.21% | ₹169.1 Cr |
| Nippon India Pharma FundNippon India Mutual Fund | 8,23,911 | 1.61% | ₹147.6 Cr |
| Mirae Asset Multicap FundMirae Asset Mutual Fund | 4,89,834 | 1.63% | ₹87.7 Cr |
| Mirae Asset Small Cap FundMirae Asset Mutual Fund | 3,78,753 | 1.17% | ₹67.8 Cr |
Portfolios disclosed for Sep 2026. Weight is the holding as a share of the fund's assets.
Promoter and insider buying and selling
Trades made since 29 Oct 2025.Narayana Hrudayalaya insider trading
Bought on the marketBought on the market. The value each filer stated for its purchases on the exchange, added up; gifts, transfers and pledges are not counted. A purchase filed with no value is counted under the sum, not in it. Sold on the marketSold on the market. The value each filer stated for its sales on the exchange, added up; gifts, transfers and pledges are not counted. A sale filed with no value is counted under the sum, not in it.
- Promoters and promoter group0 purchases, 1 saleNo purchase₹231 CrNetNet. The value bought on the market less the value sold, over the trades whose filers stated a value.−₹231 Cr
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Narayana Hrudayalaya competitors and peers
Hospital, 40 listed companies, priced on 28 Oct 2026. The table lists the 8 companies closest to Narayana Hrudayalaya in market cap.Healthcare companies
Where the company sits among the companies nearest its size
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Manipal Health EnterprisesMANIPALHOS | 84,612 | – | – | – | – | – | – | 0.00% |
 Max Healthcare InstituteMAXHEALTH | 82,877 | 56.87 | 7.71 | +16.0% | +27.0% | 14.5% | 13.0% | 0.23% |
 Aster DM Quality CareASTERDM | 58,354 | 183.11 | – | +15.7% | +0.2% | 8.0% | 12.4% | 0.45% |
 Fortis HealthcareFORTIS | 57,339 | 54.72 | 5.79 | +17.5% | +20.7% | 11.1% | 12.7% | 0.13% |
 Global HealthMEDANTA | 34,497 | 62.02 | 8.71 | +21.3% | +4.1% | 15.1% | 14.2% | 0.04% |
 Krishna Institute of Medical SciencesKIMS | 29,594 | 144.71 | 13.17 | +30.9% | −46.2% | 9.3% | 8.7% | 0.00% |
 Dr. Agarwal's Health CareAGARWALEYE | 15,063 | 101.53 | 7.44 | – | – | 7.6% | 14.1% | 0.00% |
 Rainbow Childrens MedicareRAINBOW | 12,237 | 42.88 | 7.42 | +18.3% | +10.9% | 18.3% | 25.0% | 0.29% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Dividends
Per share, by the year it was paid for, and the latest payments.Narayana Hrudayalaya dividend history
Dividend per share, ₹, restated for later splits and bonuses
Dividend per share. The dividends declared for the year, each restated to today's share count by the splits and bonuses after its own ex-date, added up. Dividend per share in the glossaryHighest ₹4.50 a share, years to Mar 2025 and Mar 2026.
| Ex-date | Type | Per share |
|---|---|---|
| 17 Jul 2026 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. Final dividend in the glossary | ₹4.50 |
| 1 Aug 2025 | Final | ₹4.50 |
| 2 Aug 2024 | Final | ₹4.00 |
| 7 Jul 2023 | Final | ₹2.50 |
| 22 Aug 2022 | Final | ₹1.00 |
| 11 Mar 2020 | Interim | ₹1.00 |
Latest payments, as declared, by ex-date.
Latest announcements
Routine notices left out.Narayana Hrudayalaya announcements
Oct 2026
5 Oct · Commencement of commercial production/operations
Sep 2026
Narayana Hrudayalaya share price by year
Each calendar year to 2025.Narayana Hrudayalaya share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 1,892.00 | +48.6% | 2,263.20 | 1,269.10 |
| 2024 | 1,272.80 | +5.9% | 1,416.95 | 1,148.10 |
| 2023 | 1,201.95 | +58.1% | 1,260.30 | 712.15 |
| 2022 | 760.45 | +18.9% | 791.45 | 617.25 |
| 2021 | 639.50 | +42.7% | 639.50 | 383.20 |
| 2020 | 448.15 | +45.8% | 448.95 | 225.60 |
| 2019 | 307.30 | +57.5% | 310.10 | 185.95 |
| 2018 | 195.10 | −34.6% | 314.85 | 195.10 |
| 2017 | 298.25 | −13.0% | 344.35 | 283.00 |
| 2016 | 342.90 | – | 362.00 | 279.90 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before.
Recent sessions
The 9 trading days to 27 Oct 2026, as traded on NSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 27 Oct 2026 | 1,662.30 | 1,723.00 | 1,660.00 | 1,713.20 | 1,703.92 | 87,732 | 55.8% |
| 26 Oct 2026 | 1,649.90 | 1,669.20 | 1,628.10 | 1,662.30 | 1,653.10 | 1,33,181 | 56.3% |
| 23 Oct 2026 | 1,693.20 | 1,705.20 | 1,622.80 | 1,646.90 | 1,643.52 | 1,97,687 | 49.1% |
| 22 Oct 2026 | 1,722.00 | 1,722.00 | 1,678.00 | 1,693.20 | 1,688.66 | 1,02,584 | 49.9% |
| 21 Oct 2026 | 1,740.90 | 1,748.80 | 1,696.00 | 1,725.00 | 1,723.55 | 1,37,889 | 55.0% |
| 19 Oct 2026 | 1,719.40 | 1,748.10 | 1,703.00 | 1,740.90 | 1,735.74 | 1,00,860 | 50.6% |
| 16 Oct 2026 | 1,716.00 | 1,731.20 | 1,706.50 | 1,719.40 | 1,718.53 | 97,143 | 61.5% |
| 15 Oct 2026 | 1,685.00 | 1,735.00 | 1,675.70 | 1,725.40 | 1,721.84 | 1,84,677 | 57.8% |
| 14 Oct 2026 | 1,688.00 | 1,699.00 | 1,670.50 | 1,689.40 | 1,687.41 | 1,24,414 | 60.8% |
Prices in ₹ per share as traded, not adjusted.
Company details
- NSE symbol
- NH
- BSE code
- 539551
- ISIN
- INE410P01011
- Industry
- Healthcare Services
- Website
- www.narayanahealth.org
- CIN
- L85110KA2000PLC027497
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 2000
- Registered office
- No.258/A, Bommasandra Industrial Area, Anekal Taluk, Bengaluru 562158, Karnataka
- Share registrar
- KFin Technologies Ltd
- Keeps the register of shareholders and handles transfers and dividend payments
In Nifty 500, BSE 500, Nifty Midcap 150, BSE 250 SmallCap Index, BSE MidCap, Nifty Total Market